We are live on ! Find out more
HTC

Haverford Trust Company Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.64%
This Fund
S&P 500
This Quarter Est. Return
-5.37%
1 Year Est. Return
+18.64%
3 Year Est. Return
+50.3%
5 Year Est. Return
+61.01%
10 Year Est. Return
+206.86%
AUM
$7.3B
AUM Growth
-$373M
Cap. Flow
+$86.9M
Cap. Flow %
1.19%
Top 10 Hldgs %
32.86%
Holding
354
New
21
Increased
129
Reduced
137
Closed
20

Top Buys

Rank Stock Value
1
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$52.1M
2
INTU icon
Intuit
INTU
+$24.1M
3
AON icon
Aon
AON
+$18.3M
4
ITW icon
Illinois Tool Works
ITW
+$9.14M
5
UL icon
Unilever
UL
+$7.97M

Top Sells

Rank Stock Value
1
TIP icon
iShares TIPS Bond ETF
TIP
+$45.8M
2
CMCSA icon
Comcast
CMCSA
+$22.7M
3
VFC icon
VF Corp
VFC
+$18.3M
4
CVS icon
CVS Health
CVS
+$13.4M
5
ADP icon
Automatic Data Processing
ADP
+$8.4M

Sector Composition

Rank Sector Weight
1 Technology 17.13%
2 Healthcare 17.05%
3 Financials 10.87%
4 Consumer Staples 10.62%
5 Consumer Discretionary 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDV
326
iShares Core High Dividend ETF
HDV
$15B
$200K ﹤0.01%
10,965
KMI icon
327
Kinder Morgan
KMI
$70.1B
$179K ﹤0.01%
10,748
-10,308
-49% -$183K
NQP
328
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$162K ﹤0.01%
14,765
FRST icon
329
Primis Financial Corp
FRST
$405M
$121K ﹤0.01%
10,000
WBD icon
330
Warner Bros
WBD
$67.9B
$115K ﹤0.01%
10,011
-8,882
-47% -$121K
LCTX icon
331
Lineage Cell Therapeutics
LCTX
$283M
$15K ﹤0.01%
+13,612
New +$20K
AKTX
332
Akari Therapeutics
AKTX
$13.5M
$13K ﹤0.01%
+25
New +$20.6K
RDHL
333
Redhill Biopharma
RDHL
$3.65M
$5K ﹤0.01%
+10
New +$8.71K
ALC icon
334
Alcon
ALC
$36.4B
-4,006
Closed -$280K
CE icon
335
Celanese
CE
$4.92B
-1,770
Closed -$208K
COR icon
336
Cencora
COR
$63.7B
-1,422
Closed -$201K
EFV icon
337
iShares MSCI EAFE Value ETF
EFV
$30B
-5,110
Closed -$222K
EL icon
338
Estee Lauder
EL
$31.8B
-892
Closed -$227K
EMBC icon
339
Embecta
EMBC
$276M
-88,950
Closed -$2.25M
EMN icon
340
Eastman Chemical
EMN
$8.55B
-3,966
Closed -$356K
HUM icon
341
Humana
HUM
$44.8B
-522
Closed -$244K
IGLB icon
342
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
-3,910
Closed -$208K
MINT icon
343
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
-2,090
Closed -$207K
PRU icon
344
Prudential Financial
PRU
$42.2B
-3,545
Closed -$339K
TAP icon
345
Molson Coors Class B
TAP
$7.83B
-4,066
Closed -$222K
TPSC icon
346
Timothy Plan US Small Cap Core ETF
TPSC
$384M
-7,000
Closed -$202K
VOT icon
347
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
-2,292
Closed -$402K
VTR icon
348
Ventas
VTR
$44.6B
-3,934
Closed -$202K
WBA
349
DELISTED
Walgreens Boots Alliance
WBA
-5,735
Closed -$217K
WDFC icon
350
WD-40
WDFC
$3.13B
-1,375
Closed -$277K

Similar funds

Haverford Trust Company's Q3 2022 Portfolio in Review

As of Q3 2022, Haverford Trust Company held 354 positions worth $7.3B, down 4.9% from $7.67B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Haverford Trust Company's Q3 2022 filing shows 21 new, 129 increased, 137 reduced and 20 closed positions. Its largest new stake was iShares MSCI USA Quality Factor ETF: 56,305 shares worth $5.85M. The largest sale was iShares TIPS Bond ETF, an estimated $45.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Haverford Trust Company's largest Q3 2022 buy was iShares MSCI USA Quality Factor ETF: 56,305 shares worth $5.85M.
  • Haverford Trust Company added most to iShares 0-5 Year TIPS Bond ETF in Q3 2022, an estimated $52.1M increase.
  • Haverford Trust Company's biggest Q3 2022 reduction was iShares TIPS Bond ETF, cutting an estimated $45.8M.
  • Haverford Trust Company fully exited Embecta in Q3 2022, selling an estimated $2.25M.
  • Haverford Trust Company's ten largest holdings make up 33% of its $7.3B portfolio in Q3 2022.
  • Haverford Trust Company opened 21 new positions and closed 20 in Q3 2022.
  • Haverford Trust Company's portfolio value fell 4.9% quarter-over-quarter to $7.3B.

Based on Haverford Trust Company's 13F filing for Q3 2022, filed 14 Nov 2022.